EA200500481A1 - Композиция для лечения спид и ассоциированных состояний - Google Patents

Композиция для лечения спид и ассоциированных состояний

Info

Publication number
EA200500481A1
EA200500481A1 EA200500481A EA200500481A EA200500481A1 EA 200500481 A1 EA200500481 A1 EA 200500481A1 EA 200500481 A EA200500481 A EA 200500481A EA 200500481 A EA200500481 A EA 200500481A EA 200500481 A1 EA200500481 A1 EA 200500481A1
Authority
EA
Eurasian Patent Office
Prior art keywords
above extracts
anacardiaceae
aids
extracts
bombacaceae
Prior art date
Application number
EA200500481A
Other languages
English (en)
Other versions
EA013683B1 (ru
Inventor
Вилльям Асиеду
Фредерик Асиеду
Менни Эннин
Майкл Нсиа Доуду
Чарльз Антви Боатенг
Кваси Аппиах-Куби
Сет Опоку Варе
Дебра Боатенг
Кофи Ампим
Вилльям Овусу
Аквете Лекс Аджей
Original Assignee
Виллфред-Рамикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виллфред-Рамикс, Инк. filed Critical Виллфред-Рамикс, Инк.
Publication of EA200500481A1 publication Critical patent/EA200500481A1/ru
Publication of EA013683B1 publication Critical patent/EA013683B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описаны композиции для лечения СПИД и ассоциированных состояний, связанных со СПИД. Композиции включают лекарственное средство, выбираемое из экстракта по меньшей мере одного из следующих семейств растений: (1) Apocynaceae (Pleioscarpa Bicarpellata); (2) Annonaceae (Cleistopholis Patens); (3) Dichapetalaceae (Dichapetehan Madagasca Riense); (4) Annoceae (Uvaristrum Pierreanum); (5) Cynocynaceae (Strophantus Gratus); (6) Asclepiadaceae (Gongronema Latifolium); (7) Combretaceae (Combretum Racemosum); (8) Apocynaceae (Alsotonia boonei); (9) Amaranthaceae (Alternanthera Pungens); (10) Aroceae (Anchomanes Differmis); (11) Cyperaceae (Seleria Voivinil); (12) Anacardiaceae (Lannea Acida); (13) Bignoniaceae (Kigelia Africana); (14) Bombacaceae (Ceiba Pentanota); (15) Anacardiaceae (Antrocaryon Micraster) ; (16) Bombacaceae (Bombax Bounopozense); (17) Anacardiaceae (Spondias Mombin); (18) Caricaceae (Carica Papaya); (19) глицеринового эфира любого из вышеупомянутых экстрактов; (20) сапонина любого из вышеупомянутых экстрактов; (21) алкалоида любого из вышеупомянутых экстрактов; (22) белка любого из вышеупомянутых экстрактов; (23) жира любого из вышеупомянутых экстрактов; (24) сахара любого из вышеупомянутых экстрактов и (25) любой смеси любого из вышеупомянутого.Отчет о международном поиске был опубликован 2004.08.05.
EA200500481A 2002-09-12 2003-09-11 Композиция для лечения спида и связанных со спидом состояний EA013683B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/241,973 US20040052868A1 (en) 2002-09-12 2002-09-12 Composition treating for AIDS and associated conditions
PCT/US2003/028295 WO2004024071A2 (en) 2002-09-12 2003-09-11 A composition for treating aids and associated conditions

Publications (2)

Publication Number Publication Date
EA200500481A1 true EA200500481A1 (ru) 2005-08-25
EA013683B1 EA013683B1 (ru) 2010-06-30

Family

ID=31991298

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500481A EA013683B1 (ru) 2002-09-12 2003-09-11 Композиция для лечения спида и связанных со спидом состояний

Country Status (16)

Country Link
US (5) US20040052868A1 (ru)
EP (1) EP1545570A2 (ru)
JP (1) JP2006503036A (ru)
KR (3) KR100989297B1 (ru)
CN (1) CN1688328A (ru)
AP (1) AP2147A (ru)
AU (2) AU2003270469B2 (ru)
BR (1) BR0314104A (ru)
CA (1) CA2498108C (ru)
EA (1) EA013683B1 (ru)
IL (1) IL167391A (ru)
MX (1) MXPA05002781A (ru)
NZ (2) NZ577096A (ru)
OA (1) OA12921A (ru)
WO (1) WO2004024071A2 (ru)
ZA (1) ZA200502756B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040052868A1 (en) 2002-09-12 2004-03-18 William Asiedu Composition treating for AIDS and associated conditions
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
US8383166B2 (en) * 2007-12-03 2013-02-26 Sequent Scientific Limited Stable hydrophobic topical herbal formulationn
WO2009101453A1 (en) * 2008-02-13 2009-08-20 Ojo Emmanuel Oluwaseyi Sunday Compositions and methods of cure and prophylaxis of hiv/aids and related syndromes
CN101559090B (zh) * 2008-04-17 2010-11-17 霸王（广州）有限公司 一种墨旱莲皂苷类化合物的提取方法
AU2009325842A1 (en) 2008-12-08 2011-07-14 Bio-Mass Ltd. Method of treatment of diseases using Hoodia extracts
CN102724990A (zh) * 2009-07-29 2012-10-10 印第安纳大学研究及科技有限公司 药用植物的提取物及其应用
KR20130117942A (ko) * 2012-04-19 2013-10-29 남부대학교산학협력단 Ｈｉｖ 증식 억제 활성을 갖는 능소화 추출물 및 이를 유효성분으로 함유하는 에이즈 치료제
FR3021871B1 (fr) * 2014-06-10 2018-07-13 Aliou Mamadou Balde Composition a base d'anthostema senegalense utilisee comme medicament contre le sida
CN104721386B (zh) * 2015-03-27 2019-04-30 福建省漳州市中医院 一种治疗虚寒型咳喘的中药外用贴剂及其制备方法
CN104825755B (zh) * 2015-05-12 2018-06-05 河南中医药大学第一附属医院 一种治疗艾滋病外寒里热证发热的中药
KR20180086545A (ko) * 2017-01-22 2018-08-01 김화원 옻나무 추출물을 함유하는 결핵 예방용 건강식품 및 그 제조방법
CN107737198A (zh) * 2017-12-13 2018-02-27 韦永朴 一种治疗慢性咳嗽的中药组合物及其制备方法
CN110256468B (zh) * 2019-05-14 2020-09-01 山东省分析测试中心 双吲哚生物碱化合物或其药学上可接受的盐及其制备方法和应用
CN111671744B (zh) * 2020-02-28 2023-03-21 中山大学 杨梅素在制备治疗血吸虫病药物中的应用
US12011473B1 (en) 2023-11-16 2024-06-18 King Faisal University Green nanoparticle composition for treatment of histoplasmosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615023A (ja) * 1984-06-18 1986-01-10 Yasutake Hichi 低カロリ−飲食物
US4923697A (en) * 1985-04-24 1990-05-08 Bar-Ilan University Antioxidant compositions and methods
US4940726A (en) * 1989-04-26 1990-07-10 Arizona Board Of Regents Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2
US5227378A (en) 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
US5545623A (en) * 1994-06-10 1996-08-13 Akira Matsumori Method of inhibiting secretion of inflammatory cytokines
US5607673A (en) 1995-04-20 1997-03-04 C.S.S.A.H.A., Inc. Purified extract of uvaria brevistipitata and a process for obtaining the purified extract therefor
EP0841934A1 (en) * 1995-08-02 1998-05-20 Teresa J. Ingram Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome
AU5471498A (en) 1996-12-09 1998-07-03 University Of Ghana Antiviral and antibacterial activities of extracts from eight plants
JP3820307B2 (ja) 1997-10-23 2006-09-13 保芦 将人 逆転写酵素阻害剤
KR20010034764A (ko) 1998-04-07 2001-04-25 슐츠, 호와드 케네드 후천성 면역결핍증의 예방 및 치료를 위한 허브 조성물
CA2354037A1 (en) 1998-09-24 2000-03-30 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
US6455078B1 (en) 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
US20040052868A1 (en) * 2002-09-12 2004-03-18 William Asiedu Composition treating for AIDS and associated conditions

Also Published As

Publication number Publication date
US20140234454A1 (en) 2014-08-21
US8771763B2 (en) 2014-07-08
EP1545570A2 (en) 2005-06-29
ZA200502756B (en) 2006-03-29
EA013683B1 (ru) 2010-06-30
US7749544B2 (en) 2010-07-06
CA2498108A1 (en) 2004-03-25
AP2147A (en) 2010-09-24
NZ577096A (en) 2011-03-31
US20040052868A1 (en) 2004-03-18
KR100989297B1 (ko) 2010-10-22
WO2004024071A2 (en) 2004-03-25
IL167391A (en) 2011-11-30
WO2004024071A3 (en) 2004-08-05
KR101017879B1 (ko) 2011-03-04
CA2498108C (en) 2013-12-10
MXPA05002781A (es) 2005-09-30
US20140023731A1 (en) 2014-01-23
AU2003270469A1 (en) 2004-04-30
AU2003270469B2 (en) 2009-09-17
AP2005003266A0 (en) 2005-03-31
KR20050051661A (ko) 2005-06-01
JP2006503036A (ja) 2006-01-26
AU2009240851A1 (en) 2009-12-17
US20100266715A1 (en) 2010-10-21
CN1688328A (zh) 2005-10-26
BR0314104A (pt) 2005-07-19
KR20090099003A (ko) 2009-09-18
NZ591136A (en) 2012-11-30
KR20100076066A (ko) 2010-07-05
US20050181077A1 (en) 2005-08-18
OA12921A (en) 2006-10-13

Similar Documents

Publication Publication Date Title
EA200500481A1 (ru) Композиция для лечения спид и ассоциированных состояний
Giovannini et al. Medicinal plants used to treat snakebite in Central America: Review and assessment of scientific evidence
Soares et al. Medicinal plants with inhibitory properties against snake venoms
Seyedan et al. Medicinal plants and their inhibitory activities against pancreatic lipase: a review
Adewusi et al. In vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from southern Africa
Mossa et al. Amelioration of prallethrin‐induced oxidative stress and hepatotoxicity in rat by the administration of Origanum majorana essential oil
Kadir et al. Ethnopharmacological survey of medicinal plants used by traditional healers and indigenous people in Chittagong Hill Tracts, Bangladesh, for the treatment of snakebite
Kapiszewska et al. The protective ability of the Mediterranean plant extracts against the oxidative DNA damage. The role of the radical oxygen species and the polyphenol content
LS Guimaraes et al. Biodiversity as a source of bioactive compounds against snakebites
US6495170B1 (en) Method of increasing the presence of glutathione in cells
Adrião et al. Plant-derived toxin inhibitors as potential candidates to complement antivenom treatment in snakebite envenomations
Ali et al. Mitigation of Alpha-Cypermethrin-Induced Hepatotoxicity in Rats by Tribulus terrestris Rich in Antioxidant Compounds.
Ajao et al. Anxiolytic and sedative properties of hydroethanolic extract of Telfairia occidentalis leaves in mice
Rahman et al. A review study on the traditional plants has potential antidepressant property
Rose et al. Effect of antioxidants and hepatoprotective activities of methanol extract of beet root (Beta vulgaris L.) against carbon tetrachloride induced hepatotoxicity in rat models
Alghazeer et al. Antioxidant activity and hepatoprotective potential of flavonoids from Arbutus pavarii against CCl4 induced hepatic damage
Omara et al. Medicinal plants used as snake venom antidotes in East African Community: review and assessment of scientific evidences
Ogunleye et al. Chenopodium ambrosioides var. ambrosioides leaf extracts possess regenerative and ameliorative effects against mercury-induced hepatotoxicity and nephrotoxicity
Konrath et al. The potential of Brazilian native plant species used in the therapy for snakebites: A literature review
Adeoye et al. Hepatoprotective and renoprotective effect of Moringa oleifera seed oil on dichlorvos-induced toxicity in male wistar rats
Oghenevwodoko Okoro et al. Anti-oxidant and hepatoprotective effects of senecio biafrae on CCl4-induced liver damage in rats
Patil et al. Pharmacological activities of Areca catechu Linn.-a review
Monteiro et al. Phytochemical profile and investigation of the spasmolytic activity of hydroalcoholic extract of Syzygium cumini (L.) Skeels Seeds
Srinivasan et al. Jatropha: phytochemistry, pharmacology, and toxicology
Jain et al. Folkloric use of plants for treatment of epilepsy in India

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU